Equity Profile

GRDN

Guardian Pharmacy Services, Inc.

Health CareHealth Care Services$2.6B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, focusing on providing pharmacy services to long-term care facilities....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and revenues.

N/A

Revenue Growth

Revenue growth indicates the company's ability to expand its services and capture market share in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, focusing on providing pharmacy services to long-term care facilities. As the demand for specialized health care services continues to grow, GRDN plays a crucial role in ensuring that patients receive the medications they need efficiently and safely.

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian Pharmacy Services reported an EPS of $0.29, exceeding expectations by 31.82%. However, the stock experienced a slight decline of 1.77% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, analysts are cautious as there are no available estimates for this quarter, leaving investors uncertain about what to expect.

Bull Case

If GRDN continues its trend of beating EPS estimates, it could signal strong operational performance and growth potential, leading to positive investor sentiment.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant sell-off, especially given the lack of recent analyst estimates.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and will it continue the trend of exceeding previous estimates?

Given the company's strong history of beating EPS estimates, this will be a critical factor in determining market sentiment.

How is Guardian managing its costs and revenue growth in the current economic environment?

Understanding the company's approach to cost management and growth will provide insights into its operational efficiency and future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating GRDN's ability to maintain its earnings momentum, especially given its strong historical performance in beating EPS estimates.

Supporting Evidence

The company has a 100% EPS beat rate over the last four quarters, indicating strong operational management.

Options pricing suggests a significant potential move, reflecting higher expectations for volatility and performance.

Recent historical patterns show that prior-quarter beats often lead to sustained positive sentiment.

Key Risk

If EPS comes in below $0.22, it could undermine the bullish sentiment built on past performance.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is keenly focused on whether GRDN can maintain its strong performance in a challenging economic landscape.

Bull Confirmed If

An EPS of $0.30 or higher would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $0.22 would support the bear case, indicating potential operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±11.48%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If GRDN beats expectations, history suggests a potential average one-day move of +0.16%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

Should the company miss expectations, history suggests a potential decline, although specific data on average moves when missing is not available.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into revenue growth drivers and market expansion plans.
3Management's commentary on the competitive landscape in health care services.
4Details on any changes in regulatory impacts affecting operations.
5Expectations for future quarters based on current economic conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

Guardian Pharmacy Services, Inc. operates in the health care sector, focusing on providing pharmacy services to long-term care facilities....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and revenues.

N/A

Revenue Growth

Revenue growth indicates the company's ability to expand its services and capture market share in the health care sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

GRDN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 4Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+28.09%

Avg Stock Reaction

+0.16%

Last Quarter Recap

In Q1-2026, Guardian Pharmacy Services reported an EPS of $0.29, exceeding expectations by 31.82%. However, the stock experienced a slight decline of 1.77% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, analysts are cautious as there are no available estimates for this quarter, leaving investors uncertain about what to expect.

Bull Case

If GRDN continues its trend of beating EPS estimates, it could signal strong operational performance and growth potential, leading to positive investor sentiment.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant sell-off, especially given the lack of recent analyst estimates.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and will it continue the trend of exceeding previous estimates?

Given the company's strong history of beating EPS estimates, this will be a critical factor in determining market sentiment.

How is Guardian managing its costs and revenue growth in the current economic environment?

Understanding the company's approach to cost management and growth will provide insights into its operational efficiency and future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating GRDN's ability to maintain its earnings momentum, especially given its strong historical performance in beating EPS estimates.

Supporting Evidence

The company has a 100% EPS beat rate over the last four quarters, indicating strong operational management.

Options pricing suggests a significant potential move, reflecting higher expectations for volatility and performance.

Recent historical patterns show that prior-quarter beats often lead to sustained positive sentiment.

Key Risk

If EPS comes in below $0.22, it could undermine the bullish sentiment built on past performance.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is keenly focused on whether GRDN can maintain its strong performance in a challenging economic landscape.

Bull Confirmed If

An EPS of $0.30 or higher would confirm the bull case and suggest continued strong performance.

Bear Confirmed If

An EPS below $0.22 would support the bear case, indicating potential operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±11.48%

Historical Avg

±1.5%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±11.5% while GRDN has averaged ±1.5% over the last 4 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

25.9%

Calls (3K)P/C Ratio: 1.00Puts (300)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If GRDN beats expectations, history suggests a potential average one-day move of +0.16%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

Should the company miss expectations, history suggests a potential decline, although specific data on average moves when missing is not available.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into revenue growth drivers and market expansion plans.
3Management's commentary on the competitive landscape in health care services.
4Details on any changes in regulatory impacts affecting operations.
5Expectations for future quarters based on current economic conditions.